Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001193125-25-258664

Chief Scientific Officer gave up 5,644 shares (to pay taxes)

  • Chief Scientific Officer acquired 19,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mahaney Paige Chief Scientific Officer 2025-10-28 Option exercise +19,200 105,000 D: show line 1 in the form
Mahaney Paige Chief Scientific Officer 2025-10-28 Shares withheld for taxes −5,644 $2.58 $14,562 99,356 D: show line 2 in the form
Loading xslF345X05/ownership.xml…